Copyright Reports & Markets. All rights reserved.

Global Peanut Allergy Therapeutics Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Peanut Allergy Therapeutics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Product
      • 1.4.2 ANB-020
      • 1.4.3 ANN-004
      • 1.4.4 AR-101
      • 1.4.5 ASP-0892
      • 1.4.6 DBV-712
      • 1.4.7 Others
    • 1.5 Market by End User
      • 1.5.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by End User
      • 1.5.2 Clinic
      • 1.5.3 Hospital
      • 1.5.4 Home Care
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Peanut Allergy Therapeutics Market Size
      • 2.1.1 Global Peanut Allergy Therapeutics Revenue 2014-2025
      • 2.1.2 Global Peanut Allergy Therapeutics Sales 2014-2025
    • 2.2 Peanut Allergy Therapeutics Growth Rate by Regions
      • 2.2.1 Global Peanut Allergy Therapeutics Sales by Regions
      • 2.2.2 Global Peanut Allergy Therapeutics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Peanut Allergy Therapeutics Sales by Manufacturers
      • 3.1.1 Peanut Allergy Therapeutics Sales by Manufacturers
      • 3.1.2 Peanut Allergy Therapeutics Sales Market Share by Manufacturers
      • 3.1.3 Global Peanut Allergy Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Peanut Allergy Therapeutics Revenue by Manufacturers
      • 3.2.1 Peanut Allergy Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Peanut Allergy Therapeutics Revenue Share by Manufacturers (2014-2019)
    • 3.3 Peanut Allergy Therapeutics Price by Manufacturers
    • 3.4 Peanut Allergy Therapeutics Manufacturing Base Distribution, Product Types
      • 3.4.1 Peanut Allergy Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Peanut Allergy Therapeutics Product Type
      • 3.4.3 Date of International Manufacturers Enter into Peanut Allergy Therapeutics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Peanut Allergy Therapeutics Sales by Product
    • 4.2 Global Peanut Allergy Therapeutics Revenue by Product
    • 4.3 Peanut Allergy Therapeutics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Peanut Allergy Therapeutics Breakdown Data by End User

    6 North America

    • 6.1 North America Peanut Allergy Therapeutics by Countries
      • 6.1.1 North America Peanut Allergy Therapeutics Sales by Countries
      • 6.1.2 North America Peanut Allergy Therapeutics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Peanut Allergy Therapeutics by Product
    • 6.3 North America Peanut Allergy Therapeutics by End User

    7 Europe

    • 7.1 Europe Peanut Allergy Therapeutics by Countries
      • 7.1.1 Europe Peanut Allergy Therapeutics Sales by Countries
      • 7.1.2 Europe Peanut Allergy Therapeutics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Peanut Allergy Therapeutics by Product
    • 7.3 Europe Peanut Allergy Therapeutics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Peanut Allergy Therapeutics by Countries
      • 8.1.1 Asia Pacific Peanut Allergy Therapeutics Sales by Countries
      • 8.1.2 Asia Pacific Peanut Allergy Therapeutics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Peanut Allergy Therapeutics by Product
    • 8.3 Asia Pacific Peanut Allergy Therapeutics by End User

    9 Central & South America

    • 9.1 Central & South America Peanut Allergy Therapeutics by Countries
      • 9.1.1 Central & South America Peanut Allergy Therapeutics Sales by Countries
      • 9.1.2 Central & South America Peanut Allergy Therapeutics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Peanut Allergy Therapeutics by Product
    • 9.3 Central & South America Peanut Allergy Therapeutics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Peanut Allergy Therapeutics by Countries
      • 10.1.1 Middle East and Africa Peanut Allergy Therapeutics Sales by Countries
      • 10.1.2 Middle East and Africa Peanut Allergy Therapeutics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Peanut Allergy Therapeutics by Product
    • 10.3 Middle East and Africa Peanut Allergy Therapeutics by End User

    11 Company Profiles

    • 11.1 Adverum Biotechnologies Inc
      • 11.1.1 Adverum Biotechnologies Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Adverum Biotechnologies Inc Peanut Allergy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Adverum Biotechnologies Inc Peanut Allergy Therapeutics Products Offered
      • 11.1.5 Adverum Biotechnologies Inc Recent Development
    • 11.2 Aimmune Therapeutics Inc
      • 11.2.1 Aimmune Therapeutics Inc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Aimmune Therapeutics Inc Peanut Allergy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Aimmune Therapeutics Inc Peanut Allergy Therapeutics Products Offered
      • 11.2.5 Aimmune Therapeutics Inc Recent Development
    • 11.3 Alfacyte Ltd
      • 11.3.1 Alfacyte Ltd Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Alfacyte Ltd Peanut Allergy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Alfacyte Ltd Peanut Allergy Therapeutics Products Offered
      • 11.3.5 Alfacyte Ltd Recent Development
    • 11.4 Allergy Therapeutics Plc
      • 11.4.1 Allergy Therapeutics Plc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Allergy Therapeutics Plc Peanut Allergy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Allergy Therapeutics Plc Peanut Allergy Therapeutics Products Offered
      • 11.4.5 Allergy Therapeutics Plc Recent Development
    • 11.5 AnaptysBio Inc
      • 11.5.1 AnaptysBio Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 AnaptysBio Inc Peanut Allergy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 AnaptysBio Inc Peanut Allergy Therapeutics Products Offered
      • 11.5.5 AnaptysBio Inc Recent Development
    • 11.6 ASIT Biotech SA
      • 11.6.1 ASIT Biotech SA Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 ASIT Biotech SA Peanut Allergy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 ASIT Biotech SA Peanut Allergy Therapeutics Products Offered
      • 11.6.5 ASIT Biotech SA Recent Development
    • 11.7 Astellas Pharma Inc
      • 11.7.1 Astellas Pharma Inc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Astellas Pharma Inc Peanut Allergy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Astellas Pharma Inc Peanut Allergy Therapeutics Products Offered
      • 11.7.5 Astellas Pharma Inc Recent Development
    • 11.8 BioLingus AG
      • 11.8.1 BioLingus AG Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 BioLingus AG Peanut Allergy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 BioLingus AG Peanut Allergy Therapeutics Products Offered
      • 11.8.5 BioLingus AG Recent Development
    • 11.9 DBV Technologies SA
      • 11.9.1 DBV Technologies SA Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 DBV Technologies SA Peanut Allergy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 DBV Technologies SA Peanut Allergy Therapeutics Products Offered
      • 11.9.5 DBV Technologies SA Recent Development
    • 11.10 HAL Allergy BV
      • 11.10.1 HAL Allergy BV Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 HAL Allergy BV Peanut Allergy Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 HAL Allergy BV Peanut Allergy Therapeutics Products Offered
      • 11.10.5 HAL Allergy BV Recent Development
    • 11.11 Intrommune Therapeutics
    • 11.12 Sanofi
    • 11.13 Selecta Biosciences Inc

    12 Future Forecast

    • 12.1 Peanut Allergy Therapeutics Market Forecast by Regions
      • 12.1.1 Global Peanut Allergy Therapeutics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Peanut Allergy Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.2 Peanut Allergy Therapeutics Market Forecast by Product
      • 12.2.1 Global Peanut Allergy Therapeutics Sales Forecast by Product 2019-2025
      • 12.2.2 Global Peanut Allergy Therapeutics Revenue Forecast by Product 2019-2025
    • 12.3 Peanut Allergy Therapeutics Market Forecast by End User
    • 12.4 North America Peanut Allergy Therapeutics Forecast
    • 12.5 Europe Peanut Allergy Therapeutics Forecast
    • 12.6 Asia Pacific Peanut Allergy Therapeutics Forecast
    • 12.7 Central & South America Peanut Allergy Therapeutics Forecast
    • 12.8 Middle East and Africa Peanut Allergy Therapeutics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Peanut Allergy Therapeutics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Peanut Allergy Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Peanut Allergy Therapeutics market based on company, product type, end user and key regions.

      This report studies the global market size of Peanut Allergy Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Peanut Allergy Therapeutics in these regions.
      This research report categorizes the global Peanut Allergy Therapeutics market by top players/brands, region, type and end user. This report also studies the global Peanut Allergy Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Adverum Biotechnologies Inc
      Aimmune Therapeutics Inc
      Alfacyte Ltd
      Allergy Therapeutics Plc
      AnaptysBio Inc
      ASIT Biotech SA
      Astellas Pharma Inc
      BioLingus AG
      DBV Technologies SA
      HAL Allergy BV
      Intrommune Therapeutics
      Sanofi
      Selecta Biosciences Inc

      Market size by Product
      ANB-020
      ANN-004
      AR-101
      ASP-0892
      DBV-712
      Others
      Market size by End User
      Clinic
      Hospital
      Home Care

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Peanut Allergy Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Peanut Allergy Therapeutics market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Peanut Allergy Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Peanut Allergy Therapeutics submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Peanut Allergy Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Peanut Allergy Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now